ATLANTA, May 31, 2019 /PRNewswire/ -- At the 67 th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass spectrometry ...

Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...

PORTLAND, Ore.--(BUSINESS WIRE)--At the 20 th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other ...

timsTOF Ultra Further Advances Quantitative Spatial and Single-cell 4D-Proteomics and 4D-Lipidomics™, Immunopeptidomics, PTM and Protein-Protein Interactions Analysis - with Speed and Robustness These ...

Bruker Corporation BRKR recently announced its progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows at the 20 th US Human Proteome Organization Congress 2024.

At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...

Bruker Corporation BRKR recently announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the timsTOF Ultra mass spectrometer at the 71st ASMS meeting. The company ...

Bruker introduces the novel timsTOF fleX™ mass spectrometer, which includes a software-switchable MALDI source adapted to the ESI timsTOF Pro™ platform. This new, combined ESI/MALDI capability enables ...

mass spectrometer, which includes a software-switchable MALDI source adapted to the ESI timsTOF ProTM platform. This new, combined ESI/MALDI capability enables spatially-resolved omics, SpatialOMxTM, ...

Bruker introduces the novel timsTOF fleX ™ mass spectrometer, which includes a software-switchable MALDI source adapted to the ESI timsTOF Pro ™ platform. This new, combined ESI/MALDI capability ...